Stocks Overview

LAST PRICE
27.2700
TODAY'S CHANGE (%)
Trending Down-0.1500 (-0.5470%)

Bid / Lots
27.2700/ 5
Ask / Lots
27.2800/ 9
Open / Previous Close
27.6100 / 27.4200
Day Range
Low 27.2150
High 27.7000
52 Week Range
Low 25.9200
High 33.8600
Volume
860,244
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Tuesday's close: 27.42
Time	Volume	RPRX
09:32 ET	27525	27.63
09:34 ET	2400	27.5
09:36 ET	4200	27.55
09:38 ET	3090	27.58
09:39 ET	575	27.5
09:41 ET	9134	27.5101
09:43 ET	1000	27.52
09:45 ET	4509	27.52
09:48 ET	2021	27.4758
09:50 ET	3047	27.465
09:52 ET	6458	27.435
09:54 ET	2384	27.44
09:56 ET	6176	27.44
09:57 ET	6836	27.4571
09:59 ET	2867	27.43
10:01 ET	2820	27.405
10:03 ET	5818	27.285
10:06 ET	6541	27.27
10:08 ET	11971	27.305
10:10 ET	7745	27.27
10:12 ET	10343	27.23
10:14 ET	4250	27.2595
10:15 ET	50481	27.26
10:17 ET	1564	27.255
10:19 ET	11415	27.275
10:21 ET	6136	27.255
10:24 ET	2850	27.275
10:26 ET	9123	27.265
10:28 ET	9479	27.225
10:30 ET	4277	27.25
10:32 ET	7068	27.25
10:33 ET	1433	27.265
10:35 ET	10395	27.31
10:37 ET	3367	27.29
10:39 ET	4011	27.315
10:42 ET	7876	27.305
10:44 ET	5912	27.3
10:46 ET	3182	27.305
10:48 ET	17584	27.315
10:50 ET	3747	27.315
10:51 ET	5007	27.316
10:53 ET	53258	27.33
10:55 ET	4944	27.4
10:57 ET	8884	27.41
11:00 ET	4895	27.41
11:02 ET	1500	27.4
11:04 ET	10365	27.39
11:06 ET	4053	27.42
11:08 ET	6684	27.445
11:09 ET	2856	27.42
11:11 ET	2513	27.425
11:13 ET	3068	27.42
11:15 ET	4291	27.43
11:18 ET	1306	27.435
11:20 ET	4100	27.425
11:22 ET	1300	27.425
11:24 ET	5547	27.41
11:26 ET	3290	27.4001
11:27 ET	6358	27.405
11:29 ET	8567	27.415
11:31 ET	1318	27.41
11:33 ET	2350	27.415
11:36 ET	2217	27.39
11:38 ET	3700	27.365
11:40 ET	3222	27.37
11:42 ET	5074	27.37
11:44 ET	3706	27.38
11:45 ET	1376	27.36
11:47 ET	5802	27.35
11:49 ET	950	27.34
11:51 ET	5679	27.355
11:54 ET	2160	27.37
11:56 ET	4444	27.385
11:58 ET	8514	27.405
12:00 ET	2463	27.415
12:02 ET	2800	27.385
12:03 ET	511	27.385
12:05 ET	14189	27.365
12:07 ET	25229	27.35
12:09 ET	5892	27.32
12:12 ET	1476	27.32
12:14 ET	1700	27.315
12:16 ET	8614	27.285
12:18 ET	4200	27.29
12:20 ET	1200	27.28
12:21 ET	11836	27.27
12:23 ET	700	27.27
12:25 ET	4909	27.2995
12:27 ET	5714	27.29
12:30 ET	1887	27.29
12:32 ET	9100	27.305
12:34 ET	6005	27.275
12:36 ET	4999	27.285
12:38 ET	1700	27.285
12:39 ET	1449	27.285
12:41 ET	570	27.28
12:43 ET	9139	27.255
12:45 ET	2100	27.25
12:48 ET	9100	27.26
12:50 ET	700	27.255
12:52 ET	200	27.26
12:54 ET	900	27.25
12:56 ET	10155	27.26
12:57 ET	4400	27.27
12:59 ET	300	27.27
01:01 ET	6898	27.31
01:03 ET	1681	27.31
01:06 ET	524	27.3081
01:08 ET	8633	27.295
01:10 ET	2380	27.29
01:12 ET	1185	27.29
01:14 ET	1222	27.28
01:15 ET	4243	27.285
01:17 ET	7216	27.28
01:19 ET	5485	27.275
01:21 ET	2055	27.27

Data delayed at least 15 minutes.

Jun 4, 2024
- Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference, from 4:15PM ET on Tuesday Jun 04, 2024 by Dow Jones
  4:15PM ET on Tuesday Jun 04, 2024 by Dow Jones
Jun 3, 2024
- Press Release: Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes, from 5:15PM ET on Monday Jun 03, 2024 by Dow Jones
  5:15PM ET on Monday Jun 03, 2024 by Dow Jones
- Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes, from 5:15PM ET on Monday Jun 03, 2024 by Dow Jones
  5:15PM ET on Monday Jun 03, 2024 by Dow Jones
- DJ Royalty Pharma Cut to Neutral From Buy by UBS, from 12:00PM ET on Monday Jun 03, 2024 by Dow Jones
  12:00PM ET on Monday Jun 03, 2024 by Dow Jones
May 29, 2024
- DJ S&P 500 Futures Fall In Premarket Trading; Bank OZK, American Airlines Group Lag, from 7:30AM ET on Wednesday May 29, 2024 by Dow Jones
  7:30AM ET on Wednesday May 29, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesRPRX Royalty Pharma PLC	16.4B	15.3x	+1.83%
United StatesAMRX Amneal Pharmaceuticals Inc	2.1B	-12.5x	---
United StatesCTLT Catalent Inc	10.2B	-8.6x	---
United StatesJAZZ Jazz Pharmaceuticals PLC	6.9B	23.1x	-3.53%
United StatesMCKPF Mallinckrodt PLC	1.6M	0.0x	---
United StatesPBH Prestige Consumer Healthcare Inc	3.3B	16.1x	---
As of 2024-06-12

Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.

Contact Information

Headquarters: 110 East 59th StreetNEW YORK, NY, United States 10022
Phone: 212-883-0200
Fax: ---

Executives

Chairman of the Board, Chief Executive Officer: Pablo Legorreta
Vice Chairman, Executive Vice President: Christopher Hite
Chief Financial Officer, Executive Vice President: Terrance Coyne
Executive Vice President - Investments and Chief Legal Officer: George Lloyd
Executive Vice President - Research and Investments: Marshall Urist

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$16.4B
Revenue (TTM)	$2.2B
Shares Outstanding	597.4M
Dividend Yield	3.08%
Annual Dividend Rate	0.8400 USD
Ex-Dividend Date	05-16-24
Pay Date	06-14-24
Beta	0.47
EPS	$1.78
Book Value	$14.61
P/E Ratio	15.3x
Price/Sales (TTM)	7.3
Price/Cash Flow (TTM)	13.7x
Operating Margin	41.96%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Royalty Pharma PLC
NASDAQ:RPRXUnited States

Search Criteria

Charts

Recent News

Jun 4, 2024

Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference, from 4:15PM ET on Tuesday Jun 04, 2024 by Dow Jones

Jun 3, 2024

Press Release: Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes, from 5:15PM ET on Monday Jun 03, 2024 by Dow Jones

Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes, from 5:15PM ET on Monday Jun 03, 2024 by Dow Jones

DJ Royalty Pharma Cut to Neutral From Buy by UBS, from 12:00PM ET on Monday Jun 03, 2024 by Dow Jones

May 29, 2024

DJ S&P 500 Futures Fall In Premarket Trading; Bank OZK, American Airlines Group Lag, from 7:30AM ET on Wednesday May 29, 2024 by Dow Jones

Pharmaceuticals - Diversified Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar